Levitra ( DrugBank: - )


2 diseases
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1
86Pulmonary arterial hypertension1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-003761-33-ES
(EUCTR)
17/02/200525/01/2006Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDEUnicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDE Erectile DysfunctionTrade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Trade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Trade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Unidad de NeuroinmunologíaNULLNot RecruitingFemale:
Male: yes
28Phase 4Spain

86. Pulmonary arterial hypertension


Clinical trials : 1,181 Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01649739
(ClinicalTrials.gov)
September 201222/7/2012Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled IloprostPulmonary Arterial HypertensionDrug: LevitraRabin Medical CenterNULLNot yet recruiting18 Years70 YearsBoth20Phase 4Israel